Pancreatic Cancer Research

ResearcherUniversitat Autònoma de BarcelonaActive in the last 2 years

Lucy S. Oldfield

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0839-402X; OpenAlex author ID A5050444955. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
50
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 1 paper

Papers 12

  1. NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. Co-author DOI 10.1093/jnci/djaf345↗
  2. Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes. Co-author DOI 10.1001/jamanetworkopen.2025.38031↗
  3. Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. First author DOI 10.1016/j.semcancer.2025.02.009↗
  4. Prevalence of New-Onset Diabetes in Patients Undergoing Pancreatic Surgery and the Association of Glucose Dysregulation With Complications in Pancreatic Cancer. Co-author DOI 10.1097/as9.0000000000000584↗
  5. Where the metabolome meets the microbiome for pancreatic cancer detection. Co-author DOI 10.1016/j.xcrm.2023.101011↗
  6. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. Co-author DOI 10.1016/j.ebiom.2021.103802↗
  7. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early de… Co-author DOI 10.1136/bmjopen-2022-068010↗
  8. Recent advances in understanding pancreatic cancer. First author DOI 10.12703/r/11-9↗
  9. Early detection of pancreatic cancer. First author DOI 10.1016/s2468-1253(19)30416-9↗
  10. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes. Co-author DOI 10.1186/s12885-018-5161-4↗
  11. Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker. Co-author DOI 10.18632/oncotarget.26034↗
  12. Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus. Co-author DOI 10.1158/1078-0432.ccr-15-0879↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eithne Costello · 12 shared papers, 2016–2026 · strength 2.04
  2. William Greenhalf · 10 shared papers, 2016–2026 · strength 1.45
  3. Christopher Michael Halloran · 7 shared papers, 2020–2026 · strength 1.28
  4. Martyn Charles Stott · 4 shared papers, 2022–2025 · strength 0.83
  5. Irena Stefanova · 3 shared papers, 2025 · strength 0.67
  6. Robert Van Der Meer · 3 shared papers, 2022–2025 · strength 0.55
  7. Paula Ghaneh · 3 shared papers, 2022–2026 · strength 0.48
  8. John P. Neoptolemos · 4 shared papers, 2016–2026 · strength 0.41
  9. Kate Murray · 2 shared papers, 2025–2026 · strength 0.39
  10. Daniel H. Palmer · 2 shared papers, 2022–2025 · strength 0.38
  11. Lawrence N. Barrera · 2 shared papers, 2018–2026 · strength 0.30
  12. Stephen P. Pereira · 3 shared papers, 2016–2022 · strength 0.28
  13. Markus Wolfgang Büchler · 1 shared paper, 2026 · strength 0.22
  14. Pedro Antonio Pérez-Mancera · 1 shared paper, 2026 · strength 0.22
  15. Thilo Hackert · 1 shared paper, 2026 · strength 0.22
  16. Christoph Springfeld · 1 shared paper, 2026 · strength 0.22
  17. Dylan Williams · 1 shared paper, 2026 · strength 0.22
  18. Christoph W. Michalski · 1 shared paper, 2026 · strength 0.22
  19. Daniel H. Palmer · 1 shared paper, 2026 · strength 0.22
  20. Jessica Hale · 1 shared paper, 2022 · strength 0.20
  21. Claire Jenkinson · 2 shared papers, 2016–2022 · strength 0.18
  22. John F. Timms · 2 shared papers, 2016–2022 · strength 0.18
  23. Bhavana Hemantha Rao · 1 shared paper, 2025 · strength 0.17
  24. Caoimhe M. Walsh · 1 shared paper, 2025 · strength 0.17
  25. Andrei Turtoï · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.